For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231017:nRSQ2791Qa&default-theme=true
RNS Number : 2791Q Primary Health Properties PLC 17 October 2023
17 October 2023
Primary Health Properties PLC
("PHP", the "Company" or the "Group")
Update on secondary listing on the Johannesburg Stock Exchange
Primary Health Properties plc (LSE: PHP), one of the UK's leading investors in
modern primary healthcare facilities, is pleased, following the announcement
on 6 September 2023, to confirm the release of a pre-listing announcement
("PLA") relating to a secondary inward listing on the Main Board of the
Johannesburg Stock Exchange ("JSE"). The listing of PHP on the JSE is expected
to become effective on 24 October 2023.
The Company will not place or issue any new PHP shares in connection with its
application for a secondary listing on the JSE and will remain listed on the
premium segment of the Official List in London. PSG Capital Proprietary
Limited have been appointed as Corporate Advisor and Sponsor on the JSE.
PHP believes that admission to trading on the JSE will be beneficial to the
Company and its stakeholders. The Board of PHP believes that the secondary
listing can be expected to contribute to liquidity in the Group's shares
through its increased profile in the South African market, where a number of
investors have already shown strong interest in investing in PHP, driven by
its high-quality, government-backed income stream and robust operating model.
More information on Primary Health Properties PLC can be found
on www.phpgroup.co.uk (http://www.phpgroup.co.uk/)
Further details:
Harry Hyman Richard Howell
Chief Executive Officer Chief Financial Officer
Tel: +44 (0) 7973 344768 Tel: +44 (0) 7766 072272
David Rydell / Stephanie Whitmore / Hannah Ratcliff / Verity Parker
(Buchanan Communications)
Tel: +44 (0) 20 7466 5000
Legal Entity Identifier: 213800Y5CJHXOATK7X11
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCGPGWWUUPWGAQ